World High Life Plc (OTCQB:WRHLF) is pleased to announce that it has finalised an agreement with 3-time UFC Champion of the World, Georges St-Pierre, as brand ambassador for World High Life and the Company’s Love Hemp brand.

“World High Life and Love Hemp aspire to be world leading pioneers for CBD health and wellness and we are therefore thrilled to have Georges St-Pierre join our team and provide his legendary leadership and vision toward the expansion of Love Hemp’s already significant business throughout the UK and more extensively into Europe and beyond,” said Mr. David Stadnyk, Chairman and President of World High Life.


As Brand Ambassador, Mr. St-Pierre will facilitate and provide promotional services, including branding, social media, product placement, endorsement and overall support of the Company and the “Love Hemp” brand.

Georges St-Pierre Highlights

  • Born in St-Isidore, Québec, on 19 May 1981
  • 26 wins (8 by knockout, 6 by submission, 12 by decision) 2 defeats
  • Two-time Welterweight Champion of the World, including nine consecutive successful title defenses from 2008 to 2013 – Ultimate Fighting Championship (UFC)
  • Middleweight Champion of the World, 2017 – Ultimate Fighting Championship (UFC)
  • Fighter of the Year 2009 – Sports Illustrated, World MMA Awards, MMAPayout, Inside MMA, MMAJunkie
  • Canadian Athlete of the Year 2008, 2009, 2010 – Rogers Sportsnet
  • Finalist – Best Fighter 2008, 2010, 2011, 2018 – ESPY Awards
  • Most Dangerous Man of the Year 2010 – Spike Guys Choice Awards
  • 2008 MMA Fighter of the Year – Black Belt Magazine

Georges “Rush” St-Pierre, also known as “GSP,” is a Canadian professional mixed martial artist and UFC world champion who holds black belts in both Kyokushin karate and Brazilian Jiu Jitsu.

In 2006 he became the UFC Welterweight Champion. He lost the title in 2007 but subsequently regained it in front of his hometown fans of Montreal in 2008 and hasn’t lost a single title defence since then.

Georges retired from the sport on 13 December 2013, holding the UFC record for most wins in title bouts and then returned to the octagon after a four-year layoff, on 4 November 2017 at UFC 217 in New York City (Madison Square Garden), where he defeated Michael Bisping by submission in the third round to win the UFC Middleweight Championship title, becoming the fourth fighter in the history of the organization to be a multi-division champion. On 7 December 2017, after being diagnosed with ulcerative colitis, Georges vacated his UFC middleweight title and officially announced his retirement from professional MMA competition on 21 February 2019.

Recognized as one of the planet’s best pound-for-pound MMA fighters and all-around athlete, GSP lives in Montreal and still travels around the world to train with the best coaches and training partners in all disciplines.

“Using Love Hemp’s CBD products in my training helped my recovery and overall well being greatly, I embrace this opportunity to help create innovative products and grow the Love Hemp brand so that others can benefit as well,” said Mr. Georges St-Pierre. “I am committed to building great teams and getting world class results in everything I do, and the World High Life and Love Hemp team have shown me they have everything it takes to achieve that world class standard.”

Brand Ambassador Agreement

The agreement with Georges St-Pierre has been entered into with his management company Georges St-Pierre Enterprises Inc (“GSPE”) and expires on 31 December 2021, during which term Georges St-Pierre has agreed to make a number of appearances for the Company and Love Hemp Limited as well as to promote the Company and Love Hemp’s products through social media. GSPE has agreed that the initial fees due under the agreement can be settled by an issue of 69,630 new ordinary shares of 10p each in the Company (“Ordinary Shares”).

Following this issue of Ordinary Shares, for the purposes of the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules, the Company has 14,159,440 Ordinary Shares in issue, each share carrying the right to one vote. The figure of 14,159,440 should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules.

The Directors of the Company accept responsibility for the contents of this announcement.

About Love Hemp

Love Hemp is one of the UK’s leading CBD and Hemp product suppliers and has more than 40 product lines, comprising oils, sprays and vapes and a variety of edible and water-based CBD products. Love Hemp has established relationships with over 1,200 stores in the UK, including leading brands such as Ocado, Holland & Barrett and WH Smith.

About World High Life

World High Life was established by the founders of Supreme Cannabis (TSX:FIRE), and 1933 Industries (CSE:TGIF), both companies at the forefront of the legalized cannabis industry. LIFE was established to take advantage of the huge opportunities available in the UK and European legal cannabis space, which is set to be the largest in the world within five years.

For further information please contact:

David Stadnyk
Founder & CEO
World High Life PLC
North America toll-free, 1 (888) 616-WRHLF (9745)
+44 (0) 7926 397 675
info@worldhighlife.uk

NEX Exchange Corporate Adviser
Mark Anwyl/Allie Feuerlein
Peterhouse Capital Limited
+44 (0) 20 7469 0930
ma@peterhousecap.com
af@peterhousecap.com

Financial PR
Camilla Horsfall/Megan Ray
Blytheweigh
+44 (0) 20 7138 3224
Camilla.horsfall@blytheweigh.com
Megan.Ray@blytheweigh.com

For more information on World High Life please visit: https://www.worldhighlife.uk

Cautionary Note Regarding Forward Looking Information

We seek safe harbour. Some statements contained in this news release are “forward looking information” within the meaning of securities laws. Forward looking information include, but are not limited to, statements regarding the use of proceeds of the non-brokered private placement and payment of the debt settlements. Generally, forward-looking information can be identified by the use of forward-looking terminology such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates”, “believes” or variations of such words and phrases (including negative or grammatical variations) or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will be taken”, “occur” or “be achieved” or the negative connotation thereof. Investors are cautioned that forward-looking information is inherently uncertain and involves risks, assumptions and uncertainties that could cause actual results to differ materially. There can be no assurance that future developments affecting the Company will be those anticipated by management. The forward-looking information contained in this press release constitutes management’s current estimates, as of the date of this press release, with respect to the matters covered thereby. We expect that these estimates will change as new information is received. We do not undertake to update any estimate at any particular time or in response to any particular event, except as required by law.

Source

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms, is pleased to announce the appointment of Mr. Al Reese, Jr., to its Board of Directors

Mr. Reese has over 40 years experience in public and private businesses including as CFO of a formerly Nasdaq-listed energy company where he arranged finance transactions totaling over $10 billion dollars during his 20-year tenure. Mr. Reese was a Director and Chairman of the Audit Committee of a community bank in Texas for ten years until such time as it was acquired by a larger banking group in 2018.

Keep reading... Show less

Mexico looks to be closer than ever to cannabis reform, with the country releasing its regulation plans to make the drug legal in medical settings.

Meanwhile, despite the financial hardships seen recently in the Canadian cannabis market, CEOs in the country are still receiving top dollar, as per a new study.

Keep reading... Show less

Not for Distribution to United States Newswire Services or for Dissemination in the United States

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today the pricing of its previously announced best efforts overnight marketed offering (the “Offering”) of subordinate voting shares (the “Offered Securities”) of the Company at a price of C$16.00 per share for a total gross proceeds of approximately US$125 Million. The issue price represents a 3.3% discount to the last close of the Company’s subordinate voting shares traded on the Canadian Securities Exchange as of January 14, 2021. 100% of the Offering is expected to be purchased by a total of seven new and existing institutional investors, including current shareholder, Wasatch Global Investors.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN) Red Light Holland (OTC: TRUFF) (CSE: TRIP) and Aphria, Inc. (NASDAQ: APHA).

Investors are cheering new and expected legislation which is opening new market opportunities for both cannabis and psychedelics globally. Innovation in premium branding, growing technologies, manufacturing, with operational execution are key, in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders in cannabis and psychedelics:

Keep reading... Show less

Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE:LXX) (the “Company”) today announced the closing of its previously announced underwritten public offering (the “Offering”) of 1,828,571 units, each unit consisting of one share of common stock and one warrant to purchase one share of common stock at a public offering price of $5.25 per unit (all prices in US$). The warrants have an exercise price of $6.58 per share, are immediately exercisable and will expire five years following the date of issuance. In connection with the Offering, the underwriter exercised in full its option to purchase an additional 274,285 shares of common stock and additional warrants to purchase 274,285 shares of common stock. The gross proceeds from the Offering were approximately $11.04 million, before deducting underwriting discounts and estimated offering expenses. No securities were offered or sold in Canada, including through the CSE or any other trading market in Canada

H.C. Wainwright & Co. (“Wainwright”) acted as the sole book-running manager for the Offering and is a non-related party to the Company.

Keep reading... Show less